Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix® technology across existing applications and collaborate on integrating OOC technologies into its R&D platform. The partnership ...

The PhysioMimix ® OOC range of Microphysiological Systems culture advanced single- and multi-organ-on-a-chip models to produce human-specific pre-clinical safety and effectiveness data when ...

Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform. On April 24, 2025, CN Bio, a ...

By recreating human physiology in the lab, the purpose of Organ-on-a-chip (OOC) is to help mitigate the risk of late-stage clinical failures by delivering fast, accurate and clinically translatable ...